Biotherapeutics Cell Line Development Market to Reach Valuation of ~US$ 224 Mn by 2030
Biotherapeutics Cell Line Development Market to Reach Valuation of ~US$ 224 Mn by 2030
Stay updated with breaking news from Cell Line. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biotherapeutics Cell Line Development Market to Reach Valuation of ~US$ 224 Mn by 2030
In this interview, we speak to Axol Bioscience about their human iPSC-derived cells and how they have the potential to revolutionize the field of neurodegenerative disease.
With advances in molecular biology informing recent developments in vaccinology, gene therapy, and other fields of medicine, human adenoviruses (HAdVs) have been of primary importance in medical research. A recent review looks at the promises of HAdVs, their potential dangers, and future challenges.
In a recent study published in the journal Annals of Diagnostic Pathology, researchers in the United States evaluated the impact of coronavirus disease 2019 (COVID-19) on central nervous system (CNS) damage in Alzheimer's disease (AD).
LEIDEN, the Netherlands, November 1, 2022 / B3C newswire / -- ProteoNic BV, a leading provider of premium vector technology and services for efficient production of biologics, today announced the extension of its license agreement with GigaGen, a biotechnology company advancing transformative antibody drug...